(22.10.2022)-Esmail Doustkhah was selected as the world’s top 2% scientists of researchers, according to Stanford University Ranking.
- (29.08.2022)-Esmail Doustkhah was appointed as the Early Career Editorial Board member of Catalysis Communications (Elsevier, IF = 3.51).
- (29.08.2022)-“Benzodiazepine-Based Drug Discovery” was published in Elsevier! Congratulations to Dr. Farzad Zamani and all other coauthors!!